| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 09/19/2006 | US7109187 Estrogenic compounds as anti-mitotic agents |
| 09/19/2006 | US7108871 Isoflavones and saponins in defined ratios, menopause, cancer |
| 09/13/2006 | EP1534732B1 5 androsten-3-ol steroid intermediates and processes for their preparation |
| 09/13/2006 | EP1414465B1 Use of inhibitors of progesterone receptor for treating steroid resistant breast cancer |
| 09/13/2006 | EP0921774B1 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 09/13/2006 | CN1830941A Compound having hydroxycarbonyl-halogenoalkyl side chain |
| 09/13/2006 | CN1274709C Saponin industry cleaning production technology |
| 09/13/2006 | CN1274708C Process for connecting side chain to androstane compound at 17th position |
| 09/06/2006 | EP1697302A1 Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders |
| 09/06/2006 | EP1525215B1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 08/31/2006 | WO2006003013B1 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
| 08/30/2006 | EP1322660B1 17alpha-fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 08/29/2006 | US7098218 7,8,9, or 10-sulfamyl, (thio)phosphonyl, sulfonyl, or sulfonamido-naphth[2,1-f]isoquinolin-1,3-diones; drug screening; enzyme inhibitors; anticarcinogenic agents |
| 08/29/2006 | CA2270177C Transdermal administration of ment |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/23/2006 | EP1339734B1 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 08/23/2006 | EP1324762B1 Separation of cresol from mare's urine |
| 08/23/2006 | CN1820756A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 08/17/2006 | US20060183727 Estrogenic compounds as anti-mitotic agents |
| 08/16/2006 | EP1689768A2 Estrogen receptor modulators |
| 08/16/2006 | EP1689767A1 Estrogen receptor modulators |
| 08/15/2006 | US7091195 Derived from plants; for preventing or inhibiting tumor growth |
| 08/10/2006 | WO2006083618A1 NANDROLONE 17ß-CARBONATES |
| 08/09/2006 | CN1814615A 7-keto deoxy epiandrosterone and its acetate synthesizing method |
| 08/09/2006 | CN1813723A Application of gaba-receptor modulators for the preventing/or treatment of neurodegenerative diseases of the eye |
| 08/08/2006 | US7087592 Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| 08/03/2006 | US20060173201 Process for the produciton of tibolone |
| 08/02/2006 | EP1685150A2 NOVEL 17beta HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS |
| 08/02/2006 | EP1272196B1 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 08/02/2006 | CN1812767A Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations |
| 08/01/2006 | CA2191397C Method for the preparation of steroid derivative ketal |
| 07/26/2006 | CN1809364A Compositions and methods for increasing telomerase activity |
| 07/25/2006 | US7081477 Estrogenic compounds as anti-mitotic agents |
| 07/19/2006 | EP1082337B1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/19/2006 | CN1805971A Method for obtaining a natural mixture of conjugated equine estrogens |
| 07/19/2006 | CN1805970A Process for the synthesis of high purity D-(17alpha)-13-ethyl-17 -hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime |
| 07/18/2006 | US7078544 Generation of steryl or stanyl esters; obtain sample, incubate with chemical intermediates and lipase, separate lipase from reaction mixture, separate steryl and stanyl esters from sample |
| 07/13/2006 | WO2006072955A2 Physiologically synergistic mixtures of fruit components, methods of preparation thereof and methods of use thereof |
| 07/12/2006 | EP1679317A2 5-Androsten-3 -ol steroid intermediates and processes for fheir preparation |
| 07/12/2006 | EP1023074B1 Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/05/2006 | EP1675866A1 Novel triterpene derivatives, preparation thereof and use thereof |
| 07/05/2006 | EP1248626B1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/04/2006 | US7071328 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21 oh-6op) |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/27/2006 | US7067683 Industrially applicable process for the sulfamoylation of alcohols and phenols |
| 06/27/2006 | US7067682 6,7-Oxygenated steroids and uses related thereto |
| 06/27/2006 | US7067505 Di-steroidal prodrugs of estradiol |
| 06/27/2006 | US7067504 Di-steroidal prodrugs of ethinyl estradiol |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/22/2006 | WO2006003013A3 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
| 06/22/2006 | US20060135796 Antiangiogenic agents |
| 06/21/2006 | EP0941039A4 Transdermal administration of ment |
| 06/14/2006 | CN1259365C High friction coefficient rubber composite brake shoes |
| 06/08/2006 | WO2006059168A1 A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6β,7β;15β,l6β-BISMETHYLENE-17α-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Ϝ-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS |
| 06/08/2006 | WO2004085458A9 Steroid spirolactonization |
| 06/08/2006 | US20060122161 Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cycling |
| 06/07/2006 | EP1666044A1 Male contraceptive formulation comprising norethisterone |
| 06/07/2006 | EP1663933A2 Improved delivery by labile hydrophobic modification of drugs |
| 06/07/2006 | EP1121941B1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 05/31/2006 | CN1780849A Process for the production of tibolone |
| 05/31/2006 | CN1257913C 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 05/30/2006 | US7053229 Process for the production of 4-(17α-alkoxymethyl-17β-substituted 3-oxoestra-4,9-dien-11β-yl) benzaldehyde-(1E)-oxime derivatives |
| 05/30/2006 | US7053228 Cushing disease; antidepressant; modulate immunology response |
| 05/24/2006 | CN1777619A Compounds with anti-inflammatory activity |
| 05/24/2006 | CN1777618A 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos |
| 05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
| 05/24/2006 | CN1257181C Androfenic Steroid compounds and method of making and using the same |
| 05/17/2006 | EP1657247A1 Steroidal compounds for inhibiting steroid sulphotase |
| 05/17/2006 | CN1774444A Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 05/11/2006 | US20060100185 5-Androsten-3beta-ol steroid intermediates and processes for their preparation |
| 05/10/2006 | CN1769293A High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 05/09/2006 | US7041839 Therapy for hormone sensitivity disease; side effect reduction; anticancer agents |
| 05/04/2006 | WO2006015081A3 A PROCESS FOR THE PREPARATION OF 7α-ALKYLATED 19-NORSTEROIDS |
| 05/03/2006 | CN1254479C 3-methylene steroid derivative |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 04/27/2006 | US20060089340 Novel steroids and steroid mimetics; method for their production; and use thereof |
| 04/26/2006 | EP1648916A1 Method for obtaining a natural mixture of conjugated equine estrogens |
| 04/25/2006 | US7033779 Method for preparing steroids modified by yeast fermentation |
| 04/20/2006 | WO2004108088A3 Methods and compositions for interferon therapy |
| 04/18/2006 | US7030157 Hormone replacment therapy; anticancer agent; sexual disorders |
| 04/18/2006 | CA2150738C Process for preparing a 16.beta.-methyl steroid and new intermediates |
| 04/13/2006 | US20060079702 Process for making estra-4,9(10)-diene steroids |
| 04/13/2006 | US20060079576 2-methoxyestradiol in a biodegradable polymer; administered for treatment of tumors |
| 04/12/2006 | EP1644398A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/12/2006 | EP1644397A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/12/2006 | EP1644396A1 Microbial process for the preparation of 7-keto dehydroepiandrosterone and related analogs |
| 04/12/2006 | EP1644391A2 Steroid modified solatrioses |
| 04/12/2006 | EP1644009A2 Compositions and methods for increasing telomerase activity |
| 04/11/2006 | US7026306 Steroidal quinols and their use for antioxidant therapy |
| 03/30/2006 | WO2006033907A2 Methods of treating disorders having a component of mercury toxicity |
| 03/30/2006 | CA2580533A1 Methods of treating disorders having a component of mercury toxicity |
| 03/29/2006 | EP1640009A1 Estrogenic compounds as antimitotic agents |
| 03/29/2006 | EP1638988A1 Process for the synthesis of high purity d-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime |
| 03/29/2006 | EP1453851B1 Phosphoric acid isomerization of a 5(10),9(11)-diene steroid to the corresponding 4,9-diene steroid |
| 03/29/2006 | EP1379253B1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/28/2006 | US7018994 Antiestrogen compound |
| 03/28/2006 | US7018993 Androstane derivatives having various substituents at positions 7 and/or 11, a prophylactic or therapeutic agent for a disease selected from prostate cancer, benign prostatic hyperplasia, alopecia, acne, precocioous puberty |
| 03/28/2006 | US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides |
| 03/23/2006 | US20060063944 Estrone derivatives and process for producing same |